Ammar, L.; Lin, H.-Y.; Shih, S.-P.; Tsai, T.-N.; Syu, Y.-T.; Abdel-Halim, M.; Hwang, T.-L.; Abadi, A.H.
Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer. Molecules 2023, 28, 840.
https://doi.org/10.3390/molecules28020840
AMA Style
Ammar L, Lin H-Y, Shih S-P, Tsai T-N, Syu Y-T, Abdel-Halim M, Hwang T-L, Abadi AH.
Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer. Molecules. 2023; 28(2):840.
https://doi.org/10.3390/molecules28020840
Chicago/Turabian Style
Ammar, Lina, Hung-Yu Lin, Shou-Ping Shih, Tsen-Ni Tsai, Yu-Ting Syu, Mohammad Abdel-Halim, Tsong-Long Hwang, and Ashraf H. Abadi.
2023. "Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer" Molecules 28, no. 2: 840.
https://doi.org/10.3390/molecules28020840
APA Style
Ammar, L., Lin, H. -Y., Shih, S. -P., Tsai, T. -N., Syu, Y. -T., Abdel-Halim, M., Hwang, T. -L., & Abadi, A. H.
(2023). Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer. Molecules, 28(2), 840.
https://doi.org/10.3390/molecules28020840